• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔热灌注化疗后细胞减灭术并发胃肠道吻合口漏的危险因素。

The risk factors for gastrointestinal anastomotic leak after cytoreduction with hyperthermic intraperitoneal chemotherapy.

机构信息

Department of General Surgery, Dokuz Eylül University Faculty of Medicine, İzmir-Türkiye.

Department of General Surgery, Medipol University Faculty of Medicine, İstanbul-Türkiye.

出版信息

Ulus Travma Acil Cerrahi Derg. 2023 Mar;29(3):370-378. doi: 10.14744/tjtes.2023.52358.

DOI:10.14744/tjtes.2023.52358
PMID:36880628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10225823/
Abstract

BACKGROUND

Gastrointestinal anastomotic leak (GAL) is a major cause of morbidity and mortality after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The aim of this study is to determine the risk factors associated with GAL in peritoneal metastases (PM) surgery.

METHODS

Patients who underwent CRS and HIPEC with gastrointestinal anastomosis were included. Charlson Comorbidity Index (CCI) and Eastern Cooperative Oncology Group (ECOG) performance status were used to assess preoperative condition of the patients. GAL was recorded as gastrointestinal extralumination diagnosed clinically, radiologicaly, or during reoperation.

RESULTS

Among 362 patients who were analyzed, the median age was 54 years, 72.6% were female, and the most common histopathologies were ovarian cancer (37.8%) and colorectal (36.2%) cancer. The median Peritoneal Cancer Index was 11 and 80.1% of the patients underwent complete cytoreduction. A single anastomosis was performed in 293 (80.9%) patients, two anastomoses in 51 (14.1%) and three anastomoses in 18 (5%) patients. Diverting stoma was performed in 43 (11.8%) patients. GAL was seen in 38 (10.5%) patients. Smoking (p<0.001), ECOG performance status (p=0.014), CCI score (p=0.009), pre-operative albumin level (p=0.010), and number of resected organs (p=0.006) were significantly associated factors with GAL. Independent risk factors for GAL were smoking (Odds Radio [OR]: 6.223, confidence interval [CI]: 2.814-13.760; p<0.001), CCI score ≥7 (OR: 4.252, CI: 1.590-11.366; p=0.004), and pre-operative albumin level ≤3.5 g/dl (OR: 3.942, CI: 1.534-10.130; p=0.004).

CONCLUSION

Patient-related factors such as smoking, comorbidity, and pre-operative nutritional status had an impact on anasto-motic complications. Proper patient selection and prediction of an index patient requiring a prehabilitation program with a high level of care are essential prerequisites to obtaining lower anastomotic leak rates and improving outcomes in PM surgery.

摘要

背景

胃肠道吻合口漏(GAL)是细胞减灭术(CRS)和腹腔热灌注化疗(HIPEC)后发病率和死亡率的主要原因。本研究旨在确定与腹膜转移(PM)手术中 GAL 相关的危险因素。

方法

纳入接受 CRS 和 HIPEC 并进行胃肠道吻合的患者。Charlson 合并症指数(CCI)和东部合作肿瘤学组(ECOG)表现状态用于评估患者术前状况。GAL 是通过临床、放射学或再次手术诊断的胃肠道外渗来记录的。

结果

在分析的 362 名患者中,中位年龄为 54 岁,72.6%为女性,最常见的组织病理学是卵巢癌(37.8%)和结直肠癌(36.2%)。中位腹膜癌指数为 11,80.1%的患者行完全肿瘤减灭术。293 名(80.9%)患者行单吻合,51 名(14.1%)患者行双吻合,18 名(5%)患者行三吻合。43 名(11.8%)患者行转流性造口术。38 名(10.5%)患者发生 GAL。吸烟(p<0.001)、ECOG 表现状态(p=0.014)、CCI 评分(p=0.009)、术前白蛋白水平(p=0.010)和切除器官数量(p=0.006)与 GAL 显著相关。GAL 的独立危险因素是吸烟(优势比 [OR]:6.223,置信区间 [CI]:2.814-13.760;p<0.001)、CCI 评分≥7(OR:4.252,CI:1.590-11.366;p=0.004)和术前白蛋白水平≤3.5 g/dl(OR:3.942,CI:1.534-10.130;p=0.004)。

结论

患者相关因素如吸烟、合并症和术前营养状况对吻合口并发症有影响。适当的患者选择和预测需要高水平护理的康复计划的指数患者是获得较低吻合口漏率和改善 PM 手术结果的必要前提。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f40d/10225823/554b7ec77f7a/TJTES-29-370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f40d/10225823/554b7ec77f7a/TJTES-29-370-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f40d/10225823/554b7ec77f7a/TJTES-29-370-g001.jpg

相似文献

1
The risk factors for gastrointestinal anastomotic leak after cytoreduction with hyperthermic intraperitoneal chemotherapy.腹腔热灌注化疗后细胞减灭术并发胃肠道吻合口漏的危险因素。
Ulus Travma Acil Cerrahi Derg. 2023 Mar;29(3):370-378. doi: 10.14744/tjtes.2023.52358.
2
Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC).减瘤手术(CRS)联合腹腔热灌注化疗(HIPEC)后胃肠道漏的预后因素及意义
Ann Surg Oncol. 2017 Apr;24(4):890-897. doi: 10.1245/s10434-016-5738-6. Epub 2016 Dec 19.
3
Anastomotic leakage after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal cancer.结直肠癌经细胞减灭术(CRS)联合腹腔热灌注化疗(HIPEC)后的吻合口漏。
Eur J Surg Oncol. 2022 Dec;48(12):2460-2466. doi: 10.1016/j.ejso.2022.05.018. Epub 2022 May 22.
4
Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).行细胞减灭术(CRS)和腹腔内热灌注化疗(HIPEC)患者发生胃肠道穿孔和吻合口漏的危险因素。
Eur J Surg Oncol. 2023 Oct;49(10):107020. doi: 10.1016/j.ejso.2023.107020. Epub 2023 Aug 14.
5
Rectal anastomosis and hyperthermic intraperitoneal chemotherapy: Should we avoid diverting loop ileostomy?直肠吻合术和腹腔内热灌注化疗:我们是否应该避免转流回肠造口术?
Eur J Surg Oncol. 2021 Sep;47(9):2346-2351. doi: 10.1016/j.ejso.2021.02.017. Epub 2021 Feb 19.
6
[Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].1384例腹膜癌病患者接受细胞减灭术加腹腔内热灌注化疗的疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Mar 25;24(3):230-239. doi: 10.3760/cma.j.cn.441530-20201110-00603.
7
Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian Cancer.晚期上皮性卵巢癌患者行间隔减瘤术联合或不联合腹腔热灌注化疗后吻合口漏的发生情况。
Gynecol Oncol. 2021 Sep;162(3):645-651. doi: 10.1016/j.ygyno.2021.06.034. Epub 2021 Jul 9.
8
Implications of Stoma Formation as Part of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.造口形成作为肿瘤细胞减灭术和腹腔热灌注化疗一部分的意义。
World J Surg. 2018 Jul;42(7):2036-2042. doi: 10.1007/s00268-017-4450-4.
9
Colorectal anastomosis during cytoreductive radical surgery in patients with peritoneal surface malignancies. Validation of a new technique (without stoma) to prevent anastomosis leakage in more than 1000 procedures.结直肠吻合术在腹膜表面恶性肿瘤的细胞减灭性根治术中的应用。一种新的(无造口)技术来预防 1000 多例吻合口漏的验证。
Clin Transl Oncol. 2021 Jun;23(6):1201-1209. doi: 10.1007/s12094-020-02511-7. Epub 2021 Jan 3.
10
[Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].[用于预测接受细胞减灭术加腹腔内热灌注化疗的结直肠癌伴腹膜转移患者预后的列线图的构建与评估]
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 May 25;26(5):434-441. doi: 10.3760/cma.j.cn441530-20230309-00071.

引用本文的文献

1
Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: a comprehensive review of clinical outcomes.伴有腹膜转移的癌症患者接受细胞减灭术和热灌注化疗手术后面临的挑战:临床结局的全面综述
Front Surg. 2024 Dec 2;11:1498529. doi: 10.3389/fsurg.2024.1498529. eCollection 2024.
2
Risk factors for postoperative complications in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: A meta-analysis and systematic review.行细胞减灭术联合腹腔热灌注化疗患者术后并发症的危险因素:荟萃分析和系统评价。
Int J Colorectal Dis. 2024 Oct 18;39(1):167. doi: 10.1007/s00384-024-04741-5.

本文引用的文献

1
Safe Anastomoses without Ostomies in Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy: Technical Considerations and Modifications.腹腔内热灌注化疗的细胞减灭术中安全吻合而无需造口术:技术考虑和改进。
Ann Surg Oncol. 2021 Nov;28(12):7784-7792. doi: 10.1245/s10434-021-09842-x. Epub 2021 Apr 14.
2
Rectal anastomosis and hyperthermic intraperitoneal chemotherapy: Should we avoid diverting loop ileostomy?直肠吻合术和腹腔内热灌注化疗:我们是否应该避免转流回肠造口术?
Eur J Surg Oncol. 2021 Sep;47(9):2346-2351. doi: 10.1016/j.ejso.2021.02.017. Epub 2021 Feb 19.
3
Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?
根治性手术和腹腔内热灌注化疗后吻合口失败的预测因素:技术重要吗?
Ann Surg Oncol. 2020 Mar;27(3):783-792. doi: 10.1245/s10434-019-07964-x. Epub 2019 Oct 28.
4
Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures.细胞减灭术联合腹腔内热化疗与其他高危手术肿瘤学程序相比的发病率和死亡率。
JAMA Netw Open. 2019 Jan 4;2(1):e186847. doi: 10.1001/jamanetworkopen.2018.6847.
5
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence.细胞减灭术联合腹腔热灌注化疗可提高结直肠癌腹膜转移癌患者的生存率:当前证据的系统评价和荟萃分析
Oncotarget. 2017 Apr 27;8(33):55657-55683. doi: 10.18632/oncotarget.17497. eCollection 2017 Aug 15.
6
Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?在热灌注化疗(HIPEC)期间进行盆腔吻合术时是否需要粪便转流?
Ann Surg Oncol. 2017 Aug;24(8):2122-2128. doi: 10.1245/s10434-017-5853-z. Epub 2017 Apr 14.
7
Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC).减瘤手术(CRS)联合腹腔热灌注化疗(HIPEC)后胃肠道漏的预后因素及意义
Ann Surg Oncol. 2017 Apr;24(4):890-897. doi: 10.1245/s10434-016-5738-6. Epub 2016 Dec 19.
8
Short-term outcome in patients treated with cytoreduction and HIPEC compared to conventional colon cancer surgery.与传统结肠癌手术相比,接受细胞减灭术和腹腔热灌注化疗(HIPEC)治疗的患者的短期预后。
Medicine (Baltimore). 2016 Oct;95(41):e5111. doi: 10.1097/MD.0000000000005111.
9
Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.细胞减灭术和腹腔内热化疗后腹膜恶性肿瘤患者的肠皮肤瘘:发病率、管理及结局
Surg Oncol. 2016 Sep;25(3):315-20. doi: 10.1016/j.suronc.2016.05.025. Epub 2016 May 24.
10
Digestive fistulas after cytoreductive surgery & HIPEC in peritoneal carcinomatosis.
J BUON. 2015 May;20 Suppl 1:S60-3.